[Polychemotherapy with platidiam and prospidin in disseminated squamous-cell lung cancer].
The effectiveness of combination chemotherapy with platidiam and prospidin was assessed in 58 patients with squamous-cell lung cancer. Complete or partial remissions were achieved in 48.3% of cases. Toxicity was moderate. The addition of gamma-ray teletherapy after chemotherapy in the total focal dose of 60-70 Gy was followed by an increase in the remission rate (88.9%) and mean survival (from 8.5 +/- 1.3 to 16.0 +/- 3.5 months).
Iu B
IuB
Mishin
K K
KK
Bel'skiĭ
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011447:Prospidium / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D012074:Remission Induction; D013997:Time Factors
D011447:Prospidium; D002945:Cisplatin
Polikhimioterapiia s platidiamom i prospidinom pri rasprostranennom ploskokletochnom rake legkogo.